Rankings
▼
Calendar
LFMD Q1 2025 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena
LFMD
LifeMD, Inc.
$182M
Q1 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$66M
+48.8% YoY
Gross Profit
$57M
86.8% margin
Operating Income
$3M
3.9% margin
Net Income
$1M
2.1% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+2.2%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$201,049
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$74M
Total Liabilities
$74M
Stockholders' Equity
-$2M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$66M
$44M
+48.8%
Gross Profit
$57M
$40M
+44.3%
Operating Income
$3M
-$6M
+141.2%
Net Income
$1M
-$7M
+120.5%
← FY 2025
All Quarters
Q2 2025 →